|
[1]
|
李贺, 郑荣寿, 张思维, 等. 2014年中国女性乳腺癌发病与死亡分析[J]. 中华肿瘤杂志, 2018, 40(3): 166-171.
|
|
[2]
|
Gelmon, K., Dent, R., Mackey, J.R., et al. (2012) Targeting Triple-Negative Breast Cancer: Optimising Therapeutic Outcomes. Annals of Oncology, 23, 2223-2234. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
黎辉, 韩明其, 陈明光. 三阴性乳腺癌的病理特征及临床预后探讨[J]. 中外医疗, 2020, 39(2): 29-31.
|
|
[4]
|
Liedtke, C., Rody, A. and Gluz, O. (2015) The Prognostic Impact of Age in Different Molecular Subtypes of Breast Cancer. Breast Cancer Research and Treatment, 152, 667-673. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Cinkaya, A., Akin, M. and Sengul, A. (2016) Evaluation of Treatment Outcomes of Triple-Negative Breast Cancer. Journal of Cancer Research and Therapeutics, 12, 150-154. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
曹晓珊, 丛斌斌. 精准医学时代三阴性乳腺癌治疗的研究进展[J]. 中国癌症杂志, 2019, 29(12): 971-976.
|
|
[7]
|
修萌, 张频. 早期三阴性乳腺癌治疗模式及新辅助治疗研究进展[J/OL]. 肿瘤防治研究, 2020, 47(2): 53-58.
|
|
[8]
|
李甜, 周钱梅, 张卫红. PI3K/Akt/mTOR信号通路在三阴性乳腺癌治疗中的研究进展[J]. 中国肿瘤, 2018, 27(1): 40-45.
|
|
[9]
|
Yutaro, G., Aye, T., Hui, O.C.C., et al. (2020) Characteristics, Behaviour and Role of Biomarkers in Metastatic Triple-Negative Breast Cancer. Journal of Clinical Pathology, 73. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
郑健, 张雪鹏. 微小RNA在三阴性乳腺癌中的研究进展[J]. 华北理工大学学报(医学版), 2016, 18(6): 499-504.
|
|
[11]
|
冷红. 基于生物信息学筛选三阴性乳腺癌差异表达基因[D]: [硕士学位论文]. 泸州: 西南医科大学, 2019.
|
|
[12]
|
Wong, C.K., Gromisch, C., Ozturk, S., et al. (2019) MicroRNA-4417 Is a Tumor Suppressor and Prognostic Biomarker for Triple-Negative Breast Cancer. Cancer Biology & Therapy, 20, 1113-1120. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Zhou, K.R., Liu, S., Cai, L., Bin, L., et al. (n.d.) ENCORI: The Encyclopedia of RNA Interactomes.
|
|
[14]
|
Li, J.H., et al. (2014) starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and Protein-RNA Interaction Networks from Large-Scale CLIP-Seq Data. Nucleic Acids Research, 42, D92-D97. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Lewis, B.P., Burge, C.B. and Bartel, D.P. (2005) Conserved Seed Pairing, Often Flanked by Adenosines, Indicates That Thousands of Human Genes Are microRNA Targets. Cell, 120, 15. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
田亚丽, 古丽海夏•哈勒玛合拜, 张燕, 张之. 外泌体微小RNA与胰岛素抵抗的研究现状[J]. 中国临床药理学杂志, 2020, 36(8): 1016-1019.
|
|
[17]
|
武强, 赵全年, 宋卫东. PI3K/Akt/mTOR信号传导通路在肿瘤的研究进展[J]. 疾病监测与控制, 2013, 7(6): 346-347.
|
|
[18]
|
Massihnia, D., Perez, A., Bazan, V., et al. (2016) A Headlight on Liquid Biopsies: A Challenging Tool for Breast Cancer Management. Tumor Biology, 37, 4263-4273. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Guan, G.Y., Niu, X., Qiao, X., et al. (2020) Upregulation of Neural Cell Adhesion Molecule 1 (NCAM1) by hsa-miR-141-3p Suppresses Ameloblastoma Cell Migration. Medical Science Monitor, 26, e923491. [Google Scholar] [CrossRef]
|
|
[20]
|
Huang, S., Wa, Q., Pan, J., et al. (2017) Downregulation of miR-141-3p Promotes Bone Metastasis via Activating NF-kappaB Signaling in Prostate Cancer. Journal of Experimental & Clinical Cancer Research, 36, 173. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Liang, Z., Li, X., Liu, S., et al. (2019) MiR-141-3p Inhibits Cell Proliferation, Migration and Invasion by Targeting TRAF5 in Colorectal Cancer. Biochemical and Biophysical Research Communications, 514, 699-705. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Li, J.H., Zhang, Z., Du, M.Z., et al. (2018) microRNA-141-3p Fosters the Growth, Invasion, and Tumorigenesis of Cervical Cancer Cells by Targeting FOXA2. Archives of Biochemistry and Biophysics, 657, 23-30. [Google Scholar] [CrossRef] [PubMed]
|